Literature DB >> 23905945

Predictive factors for worse pathological outcomes of upper tract urothelial carcinoma: experience from a nationwide high-volume centre in China.

Xiao-Peng Chen1, Geng-Yan Xiong, Xue-Song Li, Surena F Matin, Maurice Garcia, Dong Fang, Tian-Yu Wang, Wei Yu, Kan Gong, Yi Song, Zhi-Song He, Qun He, Li-Qun Zhou.   

Abstract

OBJECTIVES: To analyse the predictive factors for worse pathological outcome (muscle invasive pT2+, non-organ-confined pT3+ or N+ and histological Grade 3) of upper tract urothelial carcinoma (UTUC) in a Chinese population from a nationwide high-volume centre in China. PATIENTS AND METHODS: Predictors were studied by retrospectively reviewing the clinicopathological data of 729 consecutive patients with UTUC treated in our centre from January 2002 to December 2010. Univariate and multivariate logistic regression analyses were used.
RESULTS: There were more female patients (56.4%) than males and more tumours were located in the ureter (52.7%) than in the pelvis. In multivariate analysis, male gender (hazard ratio [HR] 1.898, P = 0.001), sessile architecture (HR 3.249, P < 0.001), high grade (HR 5.007, P < 0.001), ipsilateral hydronephrosis (HR 4.768, P < 0.001), renal pelvis location (HR 2.620, P < 0.001) and tumour without multifocality (HR 1.639, P = 0.028) were predictive factors for muscle-invasive UTUC. Male gender (HR 2.132, P < 0.001), renal pelvis location (HR 3.466, P < 0.001), tumour without multifocality (HR 2.532, P = 0.001), sessile tumour architecture (HR 3.274, P < 0.001), and high grade (HR 3.019, P < 0.001) were predictive factors for non-organ-confined disease. Chronological old age (HR 1.047, P < 0.001), sessile tumour architecture (HR 25.192, P < 0.001), ipsilateral hydronephrosis (HR 1.689, P = 0.024), and positive urinary cytology (HR 1.997, P = 0.006) were predictive factors for histological Grade 3 UTUC.
CONCLUSIONS: There was a predominance of female patients and ureteric tumours in UTUCs of this Chinese population. Male gender, sessile architecture, tumour location, tumour without multifocality, high histological grade and preoperative ipsilateral hydronephrosis were independent predictive factors for worse pathological outcome of UTUCs.
© 2013 The Authors. BJU International © 2013 BJU International.

Entities:  

Keywords:  non-organ-confined disease; upper urinary tract carcinoma; urothelial carcinoma; worse pathological outcome

Mesh:

Year:  2013        PMID: 23905945     DOI: 10.1111/bju.12238

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  29 in total

Review 1.  Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review.

Authors:  Aurélie Mbeutcha; Morgan Rouprêt; Ashish M Kamat; Pierre I Karakiewicz; Nathan Lawrentschuk; Giacomo Novara; Jay D Raman; Christian Seitz; Evanguelos Xylinas; Shahrokh F Shariat
Journal:  World J Urol       Date:  2016-04-21       Impact factor: 4.226

2.  Tumour architecture, grade and location remain predictors of non-organ-confined upper tract urothelial carcinoma at time of radical nephroureterectomy: results from a multicenter Norwegian external validation study.

Authors:  Bjarte Almås; Stein Øverby; Ole J Halvorsen; Lars A R Reisæter; Jørg Assmus; Birgitte Carlsen; Anders Loe; Christian Beisland
Journal:  World J Urol       Date:  2019-05-23       Impact factor: 4.226

3.  Expression status of GATA3 and mismatch repair proteins in upper tract urothelial carcinoma.

Authors:  Yue Wang; Jinxia Zhang; Yunfan Wang; Shufang Wang; Yu Zhang; Qi Miao; Fei Gao; Huiying He
Journal:  Front Med       Date:  2019-04-24       Impact factor: 4.592

4.  Predictive role of preoperative hydronephrosis on poor pathological outcomes and prognosis in upper tract urothelial carcinoma patients: Experience from a nationwide high-volume center in China.

Authors:  Zheng Zhang; Dong Fang; Xiaopeng Chen; Xuesong Li; Gengyan Xiong; Lei Zhang; Qun He; Liqun Zhou
Journal:  Oncol Lett       Date:  2015-08-28       Impact factor: 2.967

5.  The prognostic impact of squamous and glandular differentiation for upper tract urothelial carcinoma patients after radical nephroureterectomy.

Authors:  Qi Tang; Gengyan Xiong; Xuesong Li; Dong Fang; Chenguang Xi; Lei Zhang; Kaiwei Yang; Lin Yao; Cuijian Zhang; Wei Yu; Qun He; Kan Gong; Zhisong He; Liqun Zhou
Journal:  World J Urol       Date:  2015-10-24       Impact factor: 4.226

Review 6.  Survival differences of patients with ureteral versus pelvicalyceal tumours: a systematic review and meta-analysis.

Authors:  Krystian Kaczmarek; Artur Lemiński; Adam Gołąb; Marcin Słojewski
Journal:  Arch Med Sci       Date:  2019-11-21       Impact factor: 3.318

7.  Nomogram predicting renal insufficiency after nephroureterectomy for upper tract urothelial carcinoma in the Chinese population: exclusion of ineligible candidates for adjuvant chemotherapy.

Authors:  Dong Fang; Qifu Zhang; Xuesong Li; Cheng Qian; Gengyan Xiong; Lei Zhang; Xiaopeng Chen; Xiaoyu Zhang; Wei Yu; Zhisong He; Liqun Zhou
Journal:  Biomed Res Int       Date:  2014-08-10       Impact factor: 3.411

8.  Concurrent Preoperative Presence of Hydronephrosis and Flank Pain Independently Predicts Worse Outcome of Upper Tract Urothelial Carcinoma.

Authors:  Hsin-Chih Yeh; Hau-Chern Jan; Wen-Jeng Wu; Ching-Chia Li; Wei-Ming Li; Hung-Lung Ke; Shu-Pin Huang; Chia-Chu Liu; Yung-Chin Lee; Sheau-Fang Yang; Peir-In Liang; Chun-Nung Huang
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

9.  Characteristics and treatment outcomes of pan-urothelial cell carcinoma: a descriptive analysis of 45 patients.

Authors:  Dong Fang; Pei Liu; Xuesong Li; Gengyan Xiong; Lei Zhang; Nirmish Singla; Guangzhi Zhao; Qun He; Zhisong He; Liqun Zhou
Journal:  Sci Rep       Date:  2015-12-10       Impact factor: 4.379

10.  High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.

Authors:  Bentao Shi; Boxing Su; Dong Fang; Yuan Tang; Gengyan Xiong; Zhongqiang Guo; Qun He; Xinyu Yang; Wei Zhao; Yinglu Guo; Xuesong Li; Liqun Zhou
Journal:  BMC Cancer       Date:  2015-05-09       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.